Candida infections in the neonate

Area of Science:

• Neonatology
• Infectious Diseases
• Mycology

Background:

• Candida infections pose a growing threat in neonatal intensive care units (NICUs), particularly affecting extremely low birth weight infants.
• Common Candida species include Candida albicans and Candida parapsilosis, with transmission occurring via vertical and horizontal routes.
• Identified risk factors for candidiasis in neonates include prior antibiotic exposure, central line use, endotracheal intubation, and previous fungal colonization.

Purpose of the Study:

• To review the epidemiology, risk factors, clinical manifestations, and treatment of Candida infections in neonates.
• To highlight the challenges in managing systemic candidiasis in this vulnerable population.
• To discuss current antifungal therapies and the emerging role of antifungal prophylaxis.

Main Methods:

• Review of existing literature on neonatal candidiasis.
• Analysis of reported risk factors, species prevalence, and common sites of infection.
• Summary of current treatment strategies and mortality rates.

Main Results:

• Candida infections are frequent in NICUs, with specific risk factors identified.
• Infections can manifest in the bloodstream, meninges, or urinary tract, often disseminating to multiple organs.
• Amphotericin and fluconazole are primary antifungal agents, and the crude mortality rate for systemic candidiasis is approximately 30%.

Conclusions:

• Candida infections represent a significant cause of morbidity and mortality in NICU populations.
• Effective prevention and management strategies are crucial for improving outcomes.
• Further research into antifungal prophylaxis may be warranted to reduce the incidence of invasive candidiasis.